Literature DB >> 33036024

Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169.

Katerina Gemenetzi1,2, Fotis Psomopoulos1,3, Alejandra A Carriles4, Maria Gounari1, Claudia Minici4, Karla Plevova5,6, Lesley-Ann Sutton3, Maria Tsagiopoulou1, Panagiotis Baliakas7, Kostas Pasentsis1, Achilles Anagnostopoulos8, Raphael Sandaltzopoulos2, Richard Rosenquist3,9, Frederic Davi10, Sarka Pospisilova5,6, Paolo Ghia11,12, Kostas Stamatopoulos1,3, Massimo Degano4, Anastasia Chatzidimitriou1,3.   

Abstract

Chronic lymphocytic leukemia (CLL) major stereotyped subset 2 (IGHV3-21/IGLV3-21, ∼2.5% of all cases of CLL) is an aggressive disease variant, irrespective of the somatic hypermutation (SHM) status of the clonotypic IGHV gene. Minor stereotyped subset 169 (IGHV3-48/IGLV3-21, ∼0.2% of all cases of CLL) is related to subset 2, as it displays a highly similar variable antigen-binding site. We further explored this relationship through next-generation sequencing and crystallographic analysis of the clonotypic B-cell receptor immunoglobulin. Branching evolution of the predominant clonotype through intraclonal diversification in the context of ongoing SHM was evident in both heavy and light chain genes of both subsets. Molecular similarities between the 2 subsets were highlighted by the finding of shared SHMs within both the heavy and light chain genes in all analyzed cases at either the clonal or subclonal level. Particularly noteworthy in this respect was a ubiquitous SHM at the linker region between the variable and the constant domain of the IGLV3-21 light chains, previously reported as critical for immunoglobulin homotypic interactions underlying cell-autonomous signaling capacity. Notably, crystallographic analysis revealed that the IGLV3-21-bearing CLL subset 169 immunoglobulin retains the same geometry and contact residues for the homotypic intermolecular interaction observed in subset 2, including the SHM at the linker region, and, from a molecular standpoint, belong to a common structural mode of autologous recognition. Collectively, our findings document that stereotyped subsets 2 and 169 are very closely related, displaying shared immunoglobulin features that can be explained only in the context of shared functional selection.
© 2021 by The American Society of Hematology.

Entities:  

Year:  2021        PMID: 33036024     DOI: 10.1182/blood.2020005216

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia.

Authors:  Antonella Nicolò; Alexandra Theresa Linder; Hassan Jumaa; Palash Chandra Maity
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

Review 2.  Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia.

Authors:  Francesco Forconi; Stuart A Lanham; Giorgia Chiodin
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

3.  Subclonal heterogeneity sheds light on the transformation trajectory in IGLV3-21R110 chronic lymphocytic leukemia.

Authors:  Lisa Paschold; Donjete Simnica; Ramon Benitez Brito; Tianjiao Zhang; Christoph Schultheiß; Christine Dierks; Mascha Binder
Journal:  Blood Cancer J       Date:  2022-03-30       Impact factor: 11.037

Review 4.  Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL.

Authors:  Andreas Agathangelidis; Anastasia Chatzidimitriou; Thomas Chatzikonstantinou; Cristina Tresoldi; Zadie Davis; Véronique Giudicelli; Sofia Kossida; Chrysoula Belessi; Richard Rosenquist; Paolo Ghia; Anton W Langerak; Frédéric Davi; Kostas Stamatopoulos
Journal:  Leukemia       Date:  2022-05-25       Impact factor: 12.883

Review 5.  Immunoglobulin Gene Sequence as an Inherited and Acquired Risk Factor for Chronic Lymphocytic Leukemia.

Authors:  Moumita Datta; Hassan Jumaa
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

6.  Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.

Authors:  Ferran Nadeu; Romina Royo; Ramon Massoni-Badosa; Heribert Playa-Albinyana; Beatriz Garcia-Torre; Martí Duran-Ferrer; Kevin J Dawson; Marta Kulis; Ander Diaz-Navarro; Neus Villamor; Juan L Melero; Vicente Chapaprieta; Ana Dueso-Barroso; Julio Delgado; Riccardo Moia; Sara Ruiz-Gil; Domenica Marchese; Ariadna Giró; Núria Verdaguer-Dot; Mónica Romo; Guillem Clot; Maria Rozman; Gerard Frigola; Alfredo Rivas-Delgado; Tycho Baumann; Miguel Alcoceba; Marcos González; Fina Climent; Pau Abrisqueta; Josep Castellví; Francesc Bosch; Marta Aymerich; Anna Enjuanes; Sílvia Ruiz-Gaspà; Armando López-Guillermo; Pedro Jares; Sílvia Beà; Salvador Capella-Gutierrez; Josep Ll Gelpí; Núria López-Bigas; David Torrents; Peter J Campbell; Ivo Gut; Davide Rossi; Gianluca Gaidano; Xose S Puente; Pablo M Garcia-Roves; Dolors Colomer; Holger Heyn; Francesco Maura; José I Martín-Subero; Elías Campo
Journal:  Nat Med       Date:  2022-08-11       Impact factor: 87.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.